Clinical trials

Investigator

Melissa E Elder

The purpose of this study is to determine the PK, safety and tolerability of multiple doses of intravenous (i.v.) secukinumab in pediatric participants with JPsA

Investigator

Melissa E Elder

Ages

2 Years - 17 Years

Sexes

All

This study is an open-label, randomized, multicenter trial that incorporates a multi-arm design comparing each of 3 non-TNFi (Tumor Necrosis Factor inhibitor) medications to a second TNFi (active control) within a sequential multiple assignment…

Investigator

Melissa E Elder

Ages

2 Years - 17 Years

Sexes

All

The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harbors a genomic variant known to be a drug target or to predict sensitivity to a drug. Note: Due to…

Investigator

Thomas J George

Ages

12 Years - N/A

Sexes

All